BIOMAT Database Logo BIOMAT Database Logo

[Effect of TA-064 on bradyarrhythmias]. 1986

Y Kobayashi, and M Nakamura, and T Yazawa, and T Baba, and H Mukai, and S Iwasaki, and Y Takeyama, and H Niitani

UI MeSH Term Description Entries
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D001919 Bradycardia Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK. Bradyarrhythmia,Bradyarrhythmias,Bradycardias
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D006329 Heart Conduction System An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. Conduction System, Heart,Conduction Systems, Heart,Heart Conduction Systems,System, Heart Conduction,Systems, Heart Conduction
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Y Kobayashi, and M Nakamura, and T Yazawa, and T Baba, and H Mukai, and S Iwasaki, and Y Takeyama, and H Niitani
Effects of a new cardiotonic agent, "TA-064", in patients with dilated cardiomyopathy--relationship between cardiac effect of TA-064 and severity of myocardial lesion.
March 1987, Japanese circulation journal,
Y Kobayashi, and M Nakamura, and T Yazawa, and T Baba, and H Mukai, and S Iwasaki, and Y Takeyama, and H Niitani
Hemodynamic effect of oral TA-064 after dobutamine in congestive heart failure.
June 1987, Japanese circulation journal,
Y Kobayashi, and M Nakamura, and T Yazawa, and T Baba, and H Mukai, and S Iwasaki, and Y Takeyama, and H Niitani
[The effects of TA-064, dopamine and isoproterenol on the acutely ischemic myocardium].
July 1985, Kokyu to junkan. Respiration & circulation,
Y Kobayashi, and M Nakamura, and T Yazawa, and T Baba, and H Mukai, and S Iwasaki, and Y Takeyama, and H Niitani
Analysis of the efficacy of the new cardiotonic agent TA-064.
August 1985, American heart journal,
Y Kobayashi, and M Nakamura, and T Yazawa, and T Baba, and H Mukai, and S Iwasaki, and Y Takeyama, and H Niitani
Effect of chronic administration of denopamine (TA-064), a new positive inotropic agent, on cardiac response of rats to denopamine.
September 1986, Japanese journal of pharmacology,
Y Kobayashi, and M Nakamura, and T Yazawa, and T Baba, and H Mukai, and S Iwasaki, and Y Takeyama, and H Niitani
Cardiovascular effects of a newly synthesized cardiotonic agent (TA-064) on normal and diseased hearts.
March 1983, The American journal of cardiology,
Y Kobayashi, and M Nakamura, and T Yazawa, and T Baba, and H Mukai, and S Iwasaki, and Y Takeyama, and H Niitani
Effects of a cardiotonic agent, TA-064, on isolated canine cerebral, coronary, femoral, mesenteric, and renal arteries.
January 1983, Journal of cardiovascular pharmacology,
Y Kobayashi, and M Nakamura, and T Yazawa, and T Baba, and H Mukai, and S Iwasaki, and Y Takeyama, and H Niitani
Studies on the affinity and selectivity of denopamine (TA-064), a new cardiotonic agent, for beta-adrenergic receptors.
July 1985, Japanese journal of pharmacology,
Y Kobayashi, and M Nakamura, and T Yazawa, and T Baba, and H Mukai, and S Iwasaki, and Y Takeyama, and H Niitani
[The assessment of the arrhythmogenicity of a newly synthesized inotropic agent, TA-064 in clinical cases].
July 1986, Kokyu to junkan. Respiration & circulation,
Y Kobayashi, and M Nakamura, and T Yazawa, and T Baba, and H Mukai, and S Iwasaki, and Y Takeyama, and H Niitani
[Acute and chronic effects of oral cardiotonic agent, denopamine (TA-064) in patients with heart failure].
May 1986, Kokyu to junkan. Respiration & circulation,
Copied contents to your clipboard!